Items in cart [4] Questions? Call 888-624-8373

Rights & Permissions Free Resources Display this book on your site! Related Titles The Threat of Pandemic Influenza: Are We Ready? Workshop Summary Ensuring an Infectious Disease Workforce: Education and Training Needs for the 21st Century - Workshop Summary Other Related Titles The Children's Vaccine Initiative: Continuing Activities (1995) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 55   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix C Acronyms and Abbreviations ARI acute respiratory infection CVI Children’s Vaccine Initiative CDC Centers for Disease Control and Prevention DTP diphtheria, tetanus, pertussis EPI Expanded Programme on Immunization Hib Haemophilus influenzae type b NIH National Institutes of Health OMP outer membrane protein PAHO Pan American Health Organization PspA pneumococcal surface protein A UNICEF United Nations Children’s Fund VFC Vaccines for Children VII Vaccine Independence Initiative WHO World Health Organization Page 55 FRONT MATTER (R1-R8) CONTENTS (R9-R10) INTRODUCTION (1-1) ARI AND MENINGOCOCCAL MENINGITIS IN THE DEVELOPING WORLD (2-4) DETERMINING VACCINE NEED (5-7) OVERCOMING SCIENTIFIC AND TECHNOLOGICAL BARRIERS (8-13) PROVING VACCINE EFFICACY: THE CHALLENGE OF DEVELOPING-COUNTRY FIELD TRIALS (14-19) INTRODUCING AN EFFECTIVE VACCINE (20-26) Involving the U.S. Public and Private Sectors in the CVI (27-27) BRINGING CLARITY TO THE CVI VISION (28-28) TRENDS IN THE GLOBAL VACCINE SITUATION (29-30) RESHAPING THE EPI (31-31) A ROLE FOR INDUSTRY (32-34) FACILITATING GREATER U.S. INVOLVEMENT (35-38) DISCUSSION SUMMARY (39-40) APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS) (41-48) APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS) (49-54) APPENDIX C: ACRONYMS AND ABBREVIATIONS (55-56)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 55
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994 Appendix C Acronyms and Abbreviations ARI acute respiratory infection CVI Children’s Vaccine Initiative CDC Centers for Disease Control and Prevention DTP diphtheria, tetanus, pertussis EPI Expanded Programme on Immunization Hib Haemophilus influenzae type b NIH National Institutes of Health OMP outer membrane protein PAHO Pan American Health Organization PspA pneumococcal surface protein A UNICEF United Nations Children’s Fund VFC Vaccines for Children VII Vaccine Independence Initiative WHO World Health Organization

OCR for page 56
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994 This page in the original is blank.

Representative terms from entire chapter:

influenzae type